Degarelix Subcutaneous and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Degarelix Subcutaneous and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: degarelix
Brand name: Firmagon
Synonyms: Degarelix (Subcutaneous)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Degarelix Subcutaneous-Insulin degludec
- Degarelix Subcutaneous-Insulin Degludec (U-100) Prefilled Pens
- Degarelix Subcutaneous-Insulin Degludec (U-100) Vials
- Degarelix Subcutaneous-Insulin Degludec (U-200) Prefilled Pens
- Degarelix Subcutaneous-Insulin degludec and liraglutide
- Degarelix Subcutaneous-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Dehistine
- Insulin aspart, recombinant Subcutaneous-Dehydrated Alcohol
- Insulin aspart, recombinant Subcutaneous-Dehydrated Alcohol Injection
- Insulin aspart, recombinant Subcutaneous-Dekpak 13 Day Taperpak
- Insulin aspart, recombinant Subcutaneous-Del-Beta
- Insulin aspart, recombinant Subcutaneous-Delacort